Hello, Fool! | Login | Signup | My Fool
Jul 19, 2008 10:40 AM ET | Site Changes | Help
Search: Tickers Company Names Players
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View Ticker Page (AMLN)
Results 41 - 50 of 54 : 12345Next »
Recs
dymwit (91.98) Submitted: 1/03/07 1:22 PM : Start Price: $36.58 AMLN Score: -17.91
takeover?
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
fatcityhk (27.82) Submitted: 1/03/07 11:55 PM : Start Price: $36.35 AMLN Score: -18.41
One drug WONDER???
popatop100 (< 20) Submitted: 1/20/07 12:33 PM : Start Price: $40.48 AMLN Score: -24.49
AMLN chart is perfect pennant
Matt8265 (88.56) Submitted: 8/16/07 8:25 AM : Start Price: $44.67 AMLN Score: -25.32
I'm beating Jim Cramer. I sell used cars and do this for 1.5 hours per week.You invest in his advice.Think about it.
rtart1 (84.17) Submitted: 5/21/07 4:39 PM : Start Price: $45.00 AMLN Score: -25.33
Dual purpose products approved for treating diabetes and obesity.
awellman (84.43) Submitted: 4/13/07 2:13 PM : Start Price: $39.80 AMLN Score: -22.21
Takeover candidate
mwehrman (< 20) Submitted: 3/01/07 1:52 PM : Start Price: $37.64 AMLN Score: -21.13
Drug approvals look good and they are targeting large markets - e.g. obesity, etc.
mblin13 (< 20) Submitted: 3/01/07 1:11 PM : Start Price: $37.57 AMLN Score: 21.07
expensive
Carol1776 (< 20) Submitted: 2/18/07 5:30 PM : Start Price: $39.93 AMLN Score: -22.11
Byetta P3 trial with improved dosing regimen completes this year. Patients
legal123 (< 20) Submitted: 2/15/07 5:10 PM : Start Price: $40.05 AMLN Score: 22.37
Remarkable that weekly
Terms & Conditions
RSS Headlines
Fool UK